论文部分内容阅读
目的探讨针对神经内科脑部血肿患者,选择微创介入疗法完成治疗后的临床效果表现。方法选取2014年3月至2015年3月神经内科脑部血肿患者30例。随机将所有脑部血肿患者分为观察组与对照组,各组15例患者。观察组:微创介入方法给予手术治疗;对照组:选择药物保守治疗方法 ;对比观察组与对照组脑部血肿患者临床治疗效果表现出的差异,在Qo L评分(生存质量评分)以及nhi SS评分(神经功能缺损评分)等方面表现出的差异。结果在治疗总好转率方面,观察组脑部血肿患者高于对照组患者极为显著(P<0.05),并且观察组改善程度优于对照组患者极为显著(P<0.05)。结论针对脑部血肿患者,选择微创介入的手术方法,可以成功将患者的脑部血肿症状清除,对患者所造成的创伤较小,患者能顺利度过脑水肿高峰期,患者的神经功能以及生存质量均可以获得显著的提高,表现较低临床疾病死亡率,值得临床广泛推广。
Objective To investigate the clinical effect of minimally invasive interventional therapy for neurosurgical patients with brain hematoma. Methods Thirty patients with brain hematoma in neurology department from March 2014 to March 2015 were selected. All patients with brain hematoma were randomly divided into observation group and control group, each group of 15 patients. The observation group: minimally invasive interventional surgery for surgical treatment; control group: the choice of drug conservative treatment; contrast observation group and control group, the clinical effect of treatment of patients with hematoma showed differences in Qo L score (quality of life score) and nhi SS Score (neurological deficit score) and other aspects of the differences shown. Results Compared with the control group, the observation group had significantly higher hematoma rate than the control group (P <0.05), and the improvement in the observation group was superior to that of the control group (P <0.05). Conclusion For patients with cerebral hematoma, the choice of minimally invasive interventional surgery can successfully remove the patient’s brain hematoma symptoms, less trauma to patients, the patient can successfully over the peak cerebral edema, the patient’s neurological function and Quality of life can be significantly improved, showing a lower mortality rate of clinical disease, it is worth widely clinical promotion.